Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 243 Neoplasms 17 Neoplasm Metastasis 15 Carcinoma, Intraductal, Noninfiltrating 11 Breast Diseases 8 Advanced Breast Cancer 8 Breast Neoplasms, Male 7 Breast Carcinoma In Situ 7 Triple Negative Breast Neoplasms 5 Ovarian Neoplasms 5 Endometrial Neoplasms 5 Arthralgia 5 Neoplasms by Site 3 Breast Cancer Metastatic 3 Uterine Cervical Neoplasms 2 Recurrence 2 Patient Compliance 2 Osteoporosis 2 Obesity 2 Multiple Endocrine Neoplasia Type 1 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasm Female 2 Vitamin D Deficiency 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Skin Diseases 1 Sexual Dysfunctions, Psychological 1 Sexual Dysfunction, Physiological 1 Seizures 1 Sarcoma 1

Interventions

liposomal doxorubicin 1 defactinib 1 Paclitaxel 1 Letrozole 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Low Grade Serous Ovarian Cancer × Anastrozole × Clear all

NCT06072781 2026-04-02

RAMP 301

Verastem, Inc.

Phase 3 Recruiting

Low Grade Serous Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡